Affinage · Plasmodium

PDX2

PF3D7_1116200 · pyridoxine biosynthesis protein PDX2

Annotated
2026-09-08
11 papers in source corpus 10 papers cited in narrative 10 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

PDX2 (PF3D7_1116200) is the glutaminase subunit of the heteromeric pyridoxal 5′-phosphate (PLP, vitamin B6) synthase complex of Plasmodium falciparum, functioning obligately together with Pdx1 in de novo vitamin B6 biosynthesis (PMID:15590634). As a free enzyme PDX2 is held in a resting state — its 1.62 Å crystal structure shows an obstructed oxyanion hole — and productive glutaminase activity is acquired only upon assembly with Pdx1, which relieves this obstruction (PMID:16339145). It hydrolyzes glutamine (Km ≈ 1.3 mM) to generate ammonia that is channeled through a transient tunnel to the Pdx1 active site, where the pentose substrate is bound as a Schiff base for PLP synthesis; within the assembled particle, PDX2 subunits decorate the dodecameric Pdx1 core (up to 12 copies), and the P. falciparum enzyme organizes into fibers (PMID:22244765). Substrate binding reinforces the interaction: L-glutamine increases PDX2 affinity for Pdx1 roughly 30-fold, and catalytic activation is mechanistically coupled to engagement of the Pdx1 αN-helix interface, while recruitment of PDX2 requires prior Pdx1 self-assembly (PMID:17950752, PMID:18350152). In live parasites, PDX2 interacts directly with Pdx1, and the PDX2-containing complex is required for de novo PLP synthesis and for detoxification of singlet oxygen, with dominant-negative PDX2 rendering intraerythrocytic parasites susceptible to ¹O₂ (PMID:22242896).

Mechanistic history

Synthesis pass · year-by-year structured walk · 10 steps
  1. 2004 High

    Established that PDX2 is the glutaminase subunit of the parasite's PLP synthase and, with Pdx1, is genuinely required for de novo vitamin B6 biosynthesis rather than being a hypothetical annotation.

    Evidence Recombinant glutaminase activity assay (specific activity 209 nmol min⁻¹ mg⁻¹, Km ≈ 1.3 mM) plus complementation of a pyridoxine-auxotroph yeast strain

    PMID:15590634

    Open questions at the time
    • Did not resolve why PDX2 requires Pdx1 for activity
    • No structural basis for the interaction
  2. 2005 High

    Explained the obligate dependence of PDX2 on Pdx1: the free enzyme is autoinhibited and only complex formation switches it on.

    Evidence 1.62 Å crystal structure of PfPdx2 revealing an obstructed oxyanion hole, with reconstitution/activity assays and a chimeric Pdx1–bacterial YaaE bi-enzyme showing species-specific interaction requirements

    PMID:16339145

    Open questions at the time
    • Structure was of PDX2 alone, not the activated complex
    • Mechanism of oxyanion-hole relief not visualized
  3. 2007 High

    Quantified the coupling between substrate binding and complex assembly, showing glutamine tightens the PDX2–Pdx1 interface and that activation is linked to the Pdx1 αN-helix.

    Evidence Isothermal titration calorimetry (~30-fold affinity increase with L-glutamine), Pdx1 αN-helix swap mutants activating B. subtilis Pdx2, homology modelling

    PMID:17950752

    Open questions at the time
    • Interface geometry inferred, not solved at high resolution
    • Kinetics of tunnel opening not measured
  4. 2008 High

    Defined the assembly hierarchy: Pdx1 self-assembly is a prerequisite for PDX2 recruitment, and PDX2 can bind and function on a hexameric scaffold whereas full PLP output requires a dodecamer.

    Evidence Site-directed mutagenesis of Pdx1 interface (R85, H88, E91) and active-site (D26, K83, K151) residues with size-exclusion chromatography, co-purification and activity assays

    PMID:18350152

    Open questions at the time
    • Did not establish stoichiometry of functional particle in vivo
    • Focused on Pdx1 residues; PDX2 interface residues not mapped
  5. 2009 Medium

    Dissociated PDX2 binding from Pdx1 oligomeric state, showing a hexameric Pdx1 mutant still binds and supports PDX2 glutaminase activity even though its own catalysis is impaired.

    Evidence Pdx1 Gly155Ala mutant analyzed by light scattering, circular dichroism, co-purification and enzyme assays

    PMID:19272411

    Open questions at the time
    • Single point mutant used to infer general principle
    • In vitro only
  6. 2010 Medium

    Parsed which Pdx1 C-terminal functions can be complemented in trans, explaining the cooperative cross-talk that PDX2 depends on for PLP output.

    Evidence Pdx1 C-terminal deletion series with enzymatic assays and mass-spectrometric detection of intermediate I320

    PMID:20837012

    Open questions at the time
    • PDX2's own contribution to intermediate chemistry not addressed
    • Findings concern Pdx1 architecture more than PDX2 directly
  7. 2012 High

    Provided the structural architecture of the working machine — random decoration of the dodecameric Pdx1 core by up to 12 PDX2 subunits, fiber formation, and a transient ammonia-transfer tunnel regulated during catalysis.

    Evidence Cryo-EM, X-ray crystallography of the complex, and site-directed mutagenesis of conserved methionines with activity assays

    PMID:22244765

    Open questions at the time
    • Physiological relevance of fibers unknown
    • Dynamics of tunnel opening/closing not directly captured
  8. 2012 High

    Confirmed the PDX2–Pdx1 interaction inside the parasite and established the physiological role of the complex in singlet-oxygen detoxification, not just PLP supply.

    Evidence In vivo pull-down from transgenic parasites, PLP quantification (12.5→36.6 µM), live-cell fluorescence, and dominant-negative PDX2/Pdx1 mutants conferring ¹O₂ sensitivity

    PMID:22242896

    Open questions at the time
    • Whether PDX2 has any moonlighting role beyond glutaminase not tested
    • Direct genetic knockout of PDX2 not reported
  9. 2013 Medium

    Validated the PDX2-containing complex as the in vivo target of a Pdx1 inhibitor, reinforcing its requirement for PLP biosynthesis in the parasite.

    Evidence Transgenic overexpression of PfPdx1 and PDX2 conferring protection against inhibitor 4PEHz in growth-inhibition assays

    PMID:23039077

    Open questions at the time
    • Inhibitor acts on Pdx1; direct effect on PDX2 not distinguished
    • Overexpression rescue is indirect evidence
  10. 2020 Medium

    Extended the assembly mechanism to a second Plasmodium species, showing polydisperse PDX2 converts to a defined 24-meric Pdx1–PDX2 particle upon mixing with dodecameric Pdx1.

    Evidence DLS, SAXS (ring-shaped Pdx1 dodecamer decorated with PDX2) and EM of the P. vivax ortholog

    PMID:32825141

    Open questions at the time
    • Catalytic parameters of P. vivax PDX2 not reported
    • In vivo relevance in P. vivax not tested

Open questions

Synthesis pass · forward-looking unresolved questions
  • How PDX2 activity is regulated in the parasite over the intraerythrocytic cycle and whether it is genetically essential remain unresolved.
  • No direct PDX2 gene-knockout phenotype in the corpus
  • Regulation and stoichiometry of the complex in vivo not established
  • PDX2 interface residues not systematically mapped

Mechanism profile

Synthesis pass · controlled-vocabulary classification
Complex memberships
Pdx1–PDX2 heteromeric PLP synthase complex (dodecameric Pdx1 core decorated by up to 12 PDX2 glutaminase subunits; 24-meric particle in P. vivax)

Evidence

Reading pass · 10 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2004 PDX2 (PfPdx2) acts as the glutaminase subunit of the P. falciparum PLP synthase complex, functioning together with PfPdx1 to catalyze glutaminase activity with a specific activity of 209 nmol min⁻¹ mg⁻¹ and a Km for glutamine of 1.3 mM; complementation of pyridoxine auxotroph yeast cells confirmed involvement of both proteins in de novo vitamin B6 biosynthesis. Recombinant protein biochemistry (glutaminase activity assay), yeast complementation assay The Journal of biological chemistry High 15590634
2005 PDX2 functions as the glutaminase subunit of the heteromeric PLP synthase complex; complex formation with Pdx1 is required for catalytic activity of either subunit. The 1.62 Å crystal structure of PfPdx2 reveals an obstructed oxyanion hole indicating a resting state that is activated upon Pdx1-Pdx2 complex formation. A chimeric bi-enzyme of Pdx1 with bacterial YaaE (a Pdx2 ortholog) forms in vivo and in vitro but does not attain full catalytic activity, emphasizing species-specific structural requirements for productive interaction. X-ray crystallography (1.62 Å structure of PfPdx2), in vitro reconstitution, glutaminase activity assay, in vivo/in vitro chimera formation The Journal of biological chemistry High 16339145
2007 Thermodynamic characterization by isothermal titration calorimetry showed that l-glutamine binding increases the affinity of PDX2 for Pdx1 approximately 30-fold and alters the thermodynamic signature of complex formation, indicating substrate-dependent tightening of the PDX2–Pdx1 interface. The complex interface is dominated by hydrophobic interactions (negative heat capacity). Swapping the αN-helix of PfPdx1 with the corresponding B. subtilis segment enabled cross-binding to B. subtilis Pdx2 and partially elicited glutaminase activity in BsPdx2, demonstrating that catalytic activation of PDX2 is mechanistically linked to formation of the Pdx1 αN-helix interface. Isothermal titration calorimetry, swap-mutant biochemistry, glutaminase activity assay, 3D homology modelling Journal of molecular biology High 17950752
2008 Mutational analysis of P. falciparum Pdx1 interface residues (R85, H88, E91 at the Pdx1:Pdx1 interface) showed that their mutation to alanine impedes both Pdx1 activity and PDX2 binding, establishing that Pdx1 self-assembly is a prerequisite for PDX2 recruitment. Mutation of active-site residues D26, K83, K151 blocked enzyme activity but did not prevent PDX2 binding or PDX2 glutaminase activity, demonstrating that PDX2 can bind a hexameric Pdx1 scaffold but full catalytic output requires a dodecameric assembly. Site-directed mutagenesis, biochemical activity assays, size-exclusion chromatography, co-purification PloS one High 18350152
2009 A Glycine-155-to-Alanine mutation in Pdx1 produces a hexameric (not dodecameric) assembly in vitro with significant secondary-structure changes, yet this mutant retains the ability to bind PDX2 and support PDX2 glutaminase activity, demonstrating that PDX2 binding does not require the full dodecameric Pdx1 state, whereas Pdx1 catalytic activity does. Static and dynamic light scattering, circular dichroism, co-purification, enzyme activity assays Biochimica et biophysica acta Medium 19272411
2010 C-terminal deletion analysis of Pdx1 dissected four distinct functions contributed by the C-terminus: Pdx1 monomer assembly, ribose 5-phosphate binding, formation of reaction intermediate I320, and PLP synthesis. PLP synthesis is the only C-terminal function that can be supplied in trans, explaining the cooperative nature of the PDX2–Pdx1 complex and the cross-talk between subunits. C-terminal deletion mutagenesis, enzymatic activity assays, mass spectrometry (intermediate detection) FEBS letters Medium 20837012
2012 Cryo-EM analysis revealed that PDX2 glutaminase subunits associate randomly (up to 12 subunits) onto the dodecameric Pdx1 core, and P. falciparum PLP synthase organizes into fibers. Crystal structure of the complex shows that an α-helix adopts an open vs. closed conformation upon substrate binding; the pentose substrate is covalently attached via its C1 in a Schiff base with Lys84 of Pdx1. A transient ammonia transfer tunnel between PDX2 and Pdx1 active sites is regulated during catalysis. Mutagenesis defined critical conserved methionines required for complex function while also showing plasticity in tunnel construction across species. Electron microscopy (EM), X-ray crystallography, site-directed mutagenesis, enzymatic assays Structure (London, England : 1993) High 22244765
2012 In vivo pull-down experiments from transgenic P. falciparum parasites overexpressing both PfPdx1 and PDX2 confirmed a direct interaction between the two proteins inside the parasite. Overexpression of the complex elevated intracellular PLP levels from 12.5 µM (wild-type) to 36.6 µM and increased tolerance to singlet oxygen (¹O₂). Dominant-negative inactive mutants of either PfPdx1 or PDX2 rendered parasites susceptible to ¹O₂, establishing that de novo PLP synthesis via the PDX2-containing complex is required for singlet oxygen detoxification. In vivo pull-down (transgenic parasite overexpression), live-cell fluorescence microscopy, PLP quantification, transcription analysis, dominant-negative mutagenesis The Biochemical journal High 22242896
2013 PDX2 assembles with Pdx1 into a heteromeric PLP synthase complex in P. falciparum; transgenic parasite lines overexpressing both PfPdx1 and PDX2 showed protection against the Pdx1 inhibitor 4PEHz (IC50 shift from 16 µM for the complex to reduced sensitivity with extra copies), confirming that the PDX2-containing complex is the in vivo target of the inhibitor and is directly required for PLP biosynthesis in the parasite. Transgenic overexpression in P. falciparum, in vitro Pdx1 inhibition assay, parasite growth inhibition assay The Biochemical journal Medium 23039077
2020 In P. vivax, PDX2 exists in monomeric and multiple oligomeric states in solution; upon mixing with dodecameric Pdx1, polydisperse PDX2 is converted to a monodispersed heteromeric 24-meric Pdx1–PDX2 (Pdx) complex, as determined by DLS, SAXS (showing a ring-shaped dodecameric Pdx1 decorated with PDX2), and electron microscopy. Dynamic light scattering (DLS), small-angle X-ray scattering (SAXS), electron microscopy (EM) International journal of molecular sciences Medium 32825141

Source papers

Stage 0 corpus · 11 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2004 Analysis of the vitamin B6 biosynthesis pathway in the human malaria parasite Plasmodium falciparum. The Journal of biological chemistry 69 15590634
2005 Vitamin B6 biosynthesis by the malaria parasite Plasmodium falciparum: biochemical and structural insights. The Journal of biological chemistry 65 16339145
2012 Assembly of the eukaryotic PLP-synthase complex from Plasmodium and activation of the Pdx1 enzyme. Structure (London, England : 1993) 26 22244765
2012 The antioxidative effect of de novo generated vitamin B6 in Plasmodium falciparum validated by protein interference. The Biochemical journal 25 22242896
2008 The assembly of the plasmodial PLP synthase complex follows a defined course. PloS one 18 18350152
2013 Exploring inhibition of Pdx1, a component of the PLP synthase complex of the human malaria parasite Plasmodium falciparum. The Biochemical journal 13 23039077
2007 Structural and thermodynamic insights into the assembly of the heteromeric pyridoxal phosphate synthase from Plasmodium falciparum. Journal of molecular biology 13 17950752
2010 Defining the structural requirements for ribose 5-phosphate-binding and intersubunit cross-talk of the malarial pyridoxal 5-phosphate synthase. FEBS letters 6 20837012
2009 Mobility of the conserved glycine 155 is required for formation of the active plasmodial Pdx1 dodecamer. Biochimica et biophysica acta 6 19272411
2020 Solution Structures and Dynamic Assembly of the 24-Meric Plasmodial Pdx1-Pdx2 Complex. International journal of molecular sciences 5 32825141
2021 Structural Dynamics and Perspectives of Vitamin B6 Biosynthesis Enzymes in Plasmodium: Advances and Open Questions. Frontiers in cellular and infection microbiology 3 34327152